Atlanta
,
USA
6 - 8 April 2024
American College of Cardiology 2024 (ACC 2024)
Presentation schedule and materials
Saturday, 06 April 2024
16:55
- 16:45
EDT
21927
ORAL PRESENTATION
Semaglutide in patients with obesity-related heart failure with preserved ejection fraction and type 2 diabetes
Mikhail N. Kosiborod1; Mark C. Petrie2; Barry A. Borlaug3; Javed Butler4; Melanie J. Davies5; G. Kees Hovingh6; Dalane W. Kitzman7; Daniél Vega Møller6; Marianne Bach Treppendahl6; Subodh Verma8; Thomas Jon Jensen6; Karoline Liisberg6; Marie L Lindegaard6; Sanjiv J. Shah9 for the STEP-HFpEF DM Trial Committees and Investigators
MATERIALS AVAILABLE
Sunday, 07 April 2024
00:15
EDT
1413-213
POSTER
Effect of semaglutide on cardiorenal outcomes by baseline body mass index and prior cardiovascular disease: pooled analysis of SUSTAIN 6 and PIONEER 6
Jingmin Zhou1; Mansoor Husain2; Yang Li3; Wenyan Liu3; Zewei Shen3; Tina Vilsbøll4; Junbo Ge1
10:15
EDT
1372-209
POSTER
Prevalence of high-sensitivity C-reactive protein testing among USA patients with atherosclerotic cardiovascular disease with or without chronic kidney disease
Lei Lv1; Jigar Rajpura1; Matt Strum1; Ty J Gluckman2
11:15
- 11:25
EDT
1065-05
SHORT ORAL PRESENTATION
Effects of 1 mg Once-Weekly Semaglutide on Functional Capacity in Patients with Type 2 Diabetes and Peripheral Artery Disease: Trial Design and Baseline Characteristics from STRIDE a 52-Week, Randomized, Double-Blind, Placebo-Controlled Trial
Marc Bonaca1; Andrei-Mircea Catarig2; Yasemin Hansen2; Kim Houlind3; Chethana Kalmady Ramesh4; Bernhard Ludvik5; Joakim Nordanstig6; Neda Rasouli7; Harald Sourij8; Subodh Verma9
12:30
- 12:40
EDT
407-10
ORAL PRESENTATION
The Diabetes Remote Intervention to improVe use of Evidence-based medications (DRIVE) Study: A randomized evaluation of a team-based remote education and medication management program to reduce CV and kidney risk
Alexander J. Blood1,2,6; Lee-Shing Chang3,6; Shahzad Hassan1,2; Jacqueline Chasse1,2; Gretchen Stern1; Daniel Gabovitch1; David Zelle1; Caitlin Colling5,6; Samuel J. Aronson1,4; Christian Figueroa1; Emma Collins1; Ryan Ruggiero1; Emily Zacherle7; Joshua Noone7; Carey Robar7; Jorge Plutzky1,2,6; Thomas A. Gaziano1,2,6; Christopher P. Cannon1,2,6; Deborah J. Wexler5,6; Benjamin M. Scirica1,2,6
Monday, 08 April 2024
11:45
EDT
1532-209
POSTER
Patient and cardiologist perspectives on the treatment of atherosclerotic cardiovascular disease and obesity
Pam Taub1; Lyn Behnke2,3,4; Michael G. Knight5; Delilah McCarty6; Carey Robar6; Andrea Traina6
Keywords